College of Pharmacy and Research Institute of Drug Development, Chonnam National University, Gwangju 500-757, Republic of Korea.
Biochem Biophys Res Commun. 2012 Sep 7;425(4):800-5. doi: 10.1016/j.bbrc.2012.07.155. Epub 2012 Aug 2.
Distal-less 3 (DLX3) is a highly conserved homeobox containing transcription factor. DLX3 is specifically expressed in osteoblasts and osteocytes of all developing bones. DLX3 is essential for osteoblast differentiation and skeletal morphogenesis and acts as a scaffold for nucleic acids and regulatory factors involved in skeletal gene expression. Akt can be activated by several osteogenic signaling molecules, but its precise function and downstream targets in bone development are unknown. In this report, we investigated a potential regulation of Dlx3 function by Akt1. We found that Akt1 phosphorylates Dlx3 and Akt1 activation increases protein stability, osteogenic activity and transcriptional activity of Dlx3. Also, BMP2 was shown to increase the protein level of Dlx3 in an Akt1 activity-dependent manner. Conversely, inhibition of Akt1 by the Akt inhibitor decreases the protein levels of Dlx3. These results suggest that Dlx3 is a novel target of Akt1 and the activity of Dlx3 could be modulated by a novel mechanism involving Akt1 during osteoblast differentiation.
远节同源盒蛋白 3(DLX3)是一种高度保守的含同源盒转录因子。DLX3 特异性表达于所有发育骨骼中的成骨细胞和骨细胞。DLX3 对于成骨细胞分化和骨骼形态发生是必需的,并作为涉及骨骼基因表达的核酸和调节因子的支架。Akt 可以被几种成骨信号分子激活,但其在骨骼发育中的精确功能和下游靶标尚不清楚。在本报告中,我们研究了 Akt1 对 Dlx3 功能的潜在调节作用。我们发现 Akt1 使 Dlx3 磷酸化,并且 Akt1 的激活增加了 Dlx3 的蛋白稳定性、成骨活性和转录活性。此外,BMP2 以 Akt1 活性依赖性方式增加 Dlx3 的蛋白水平。相反,Akt 抑制剂 Akt1 的抑制降低了 Dlx3 的蛋白水平。这些结果表明 Dlx3 是 Akt1 的一个新靶标,并且在成骨细胞分化过程中,Akt1 通过一种新的机制来调节 Dlx3 的活性。